En route for a first look at the foundational work for Frontier’s new facility at ILM.
En route for a first look at the foundational work for Frontier’s new facility at ILM.
The Road to the Max: Australia Day 16 interview with Dr. Rachel de las Heras, Ultrasound Product Development Manager at the Queensland Brain Institute, is live! Check out the full interview on PharmasAlmanac.com.
The Road to the Max: Australia Day 17 interview with Mark W. Womack, CEO of BioCina, is live! Check out the full interview on PharmasAlmanac.com.
Diseases like Alzheimer’s and dementia are complex, with multiple variables impacting our understanding. PCC is helping ensure that healthcare organizations and researchers account for the risks associated with these conditions to enhance the quality of life for patients, elevate care standards, and accelerate the development of new treatments.
Coriolis Pharma’s expertise continues to support innovators in bringing drug products to patients efficiently and safely.
Rentschler Biopharma, one of the original biologics CDMOs, is ready to book new commercial capacity following the validation of the $100M investment into its Milford, MA facility.
We never thought we’d live to see the day – Aston Villa at the top of the EU rankings.
As part of their new website, Ampersand has also rolled out their new logo and tagline. It’s a small update from the old logo, but an important and impactful one.
The new website for our favorite PE company, Ampersand Capital Partners, is LIVE! The long journey has been an enjoyable one. Special thanks to Herb, David, Geoff, Kathleen, and the rest of the Ampersand team for letting us bring this project to life for you. Check them out at www.ampersandcapital.com.
The Road to the Max: Australia Day 16 interview with Queensland University of Technology’s Dr. Wayne Johnston, Research Associate and Lecturer, Dr. James Antoney, Postdoctoral Fellow in Protein Engineering, and Mica Fiorito, Ph.D. student, is live! Check out the full interview on PharmasAlmanac.com.